Buy & Sell KraneShares Electric Vehicles and Future Mobility (KARS) – KraneShares Electric Vehicles and Future Mobility Price Today
Key Stats
- -Market Cap
- Sector/ThematicSector
- -10.08%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 12 daysTypical Hold Time
Over the past 52 weeks, KraneShares Electric Vehicles and Future Mobility has traded between a low of $20.64 and a high of $38.01, highlighting its annual price range. Over the past three months, KraneShares Electric Vehicles and Future Mobility has recorded a drawdown of -10.08%, reflecting recent price volatility. On average, investors hold KraneShares Electric Vehicles and Future Mobility for approximately 12 days, indicating typical investor behavior on the platform.
About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Most Recent News
ExxonMobil warns oil prices could spike to $160/barrel amid low inventories and geopolitical tensions.
ExxonMobil's Senior Vice President Neil Chapman warned that crude oil prices could surge to $150-$160 per barrel soon due to critically low inventory levels, despite recent price drops linked to U.S.-Iran peace talks. The company highlighted that str...

XRP shows signs of bottoming as smart money accumulates and ETFs hit best month of 2026.
XRP has shown signs of bottoming after a five-month consolidation, with smart money investors increasing accumulation. XRP ETFs recorded their best month in 2026, adding $131 million in inflows in May, contrasting with declines in Bitcoin and Ethereu...

Whitehawk reveals SEZ6 as a promising target for new cancer drug HWK-206, advancing to clinical trials in 2026.
Whitehawk Therapeutics announced data showing SEZ6 protein is highly expressed in small cell lung cancer (SCLC) and other neuroendocrine tumors, exceeding other known targets. This supports their development of HWK-206, a next-generation antibody dru...
